 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics, Inc. NASDAQ: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that it will host Sage FutureCast: An RD and Portfolio Review on Tuesday, December 14 from 8:00 a.m. to 10:00 a.m. ET. Sage FutureCast will discuss the Companys research and development strategy, and clinical progress in programs throughout 